Panbela Therapeutics Inc expected to post a loss of 25  cents a share - Earnings Preview

Panbela Therapeutics

11/05/2022 02:25

* Panbela Therapeutics Inc  PBLA.OQ   PBLA.O  is expected
to show
no change in quarterly revenue when it reports  results on May
12. 
    * ​Refinitiv's mean analyst estimate for Panbela
Therapeutics Inc
is for a loss of 25 cents per share. For the same quarter last
year, the company reported a loss of 23 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $6​, above​ its last closing price of $1.65.
​​​

This summary was machine generated May 11 at 01:24 GMT.  All
figures in US dollars  unless otherwise stated